Sleepy Fruitflies Get Mellow: Sleep Deprivation Reduces Aggression, Mating Behavior in Flies, Penn Study Finds

A team of researchers from the Perelman School of Medicine at the University of Pennsylvania used fruitflies to probe deeper into the cellular and molecular mechanisms that govern aggression and sleep. They found that sleep deprivation reduces aggression in fruitflies and affects their reproductive fitness. The team also identified a related molecular pathway that might govern recovery of normal aggressive behaviors.  The work was published in eLife this week.

First author Matthew Kayser, MD, PhD, an assistant professor of Psychiatry, and the team focused on several chemicals that have been associated with aggression in fruitflies and other species. “There has been a lot of work on these monoamines, the same ones that are potentially involved in some aspects of mammalian aggression,” explained Kayser. “We asked what happens if we try to activate dopamine receptors or octopamine [the insect version of norepinephrine in mammals], a type of monoamine, after sleep loss in flies.” 

After flies were given the chlordimeform (CDM), an octopamine agonist – a molecule that initiates a physiological response when binding to a cell-surface receptor — and the dopamine agonist L-DOPA and then sleep deprived, the researchers saw that CDM rescued aggressive behavior, but L-DOPA did not. “If you activate octopamine receptors, you rescue the fighting behavior,” said Kayser. “The other drug L-DOPA makes them really active, but they’re not fighting.” Neither drug affected fighting behaviors when flies were not sleep deprived.

Kayser notes that the relative simplicity of the fruitfly model compared to working with mammals is a more direct approach to studying the sleep-aggression link. “We first sleep deprived the flies and looked at their fighting behavior, and saw a huge, very clear effect on behavior,” he said. “Suddenly they go from fighting quite a bit to sharing resources and not fighting much.”

Kayser and his colleagues also studied the effects of reduced aggression on social behavior, specifically reproductive behavior and success. “We asked the simple question, does sleep deprivation affect sexual fitness?” The answer was yes: reduced aggressiveness of the sleep-deprived male flies clearly impaired their mating success when competing with non-sleepy males for females. Again, the molecule CDM rescued aggression and so also mating fitness in the sleep-deprived flies, while L-DOPA had no effect, reinforcing the link between aggression and octopamine signaling.

 “Not to over-anthropomorphize, but I think this reinforces the notion that aggression is important for certain things, such as mating, not just a negative behavior,” noted Kayser. “In the fly, aggression can be important for carrying on a species’ genetic code, and if you do things that impede aggression, it can have negative effects.”

Next steps include figuring out the neurobiological mechanisms that control the sleep-aggression link. “Our work suggests that somehow downstream of the sleep neuron pathway, there’s a connection with aggression neurons, so we really want to understand what those are,” said Kayser. “We have reason to think they’re octopamine neurons, but we’d like to be able to identify exactly which neurons, and then how signals from the sleep centers are relayed to these aggression centers. The role of other monoamines, such as serotonin, remains to be explored as well.”

Much of the cellular and molecular mechanisms involved in behaviors such as sleep and aggression have been found to be highly conserved across species, raising the possibility of translating the present research to humans. “I definitely see the potential for translation here, although it may be in the distant future,” said senior author Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program. Sehgal is also a Howard Hughes Medical Institute (HHMI) investigator. 

“That translation is always in the back of our minds,” added Kayser. “I have seen patients with dysregulation of aggressive behavior that’s not specific to any single disorder. If this type of work can someday open the door to a different way to effectively control, treat, or modulate aggression, that would be a pretty fantastic thing. Right now, from a pharmacological perspective, we don’t have a handle on more targeted interventions.  I think that’s a real attraction to studying aggression in the fly – to work on the cellular and molecular controls to understand the basic biology of this pathway so we can leverage this knowledge into something that is eventually clinically relevant.”

Benjamin Mainwaring and Zhifeng Yue, both from Penn, are coauthors.

The work was funded by the National Institutes of Health (K08 NS090461, T32 HL07713) and HHMI.


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report‘s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania — recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital — the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.